Philip Morris International Launches New IQOS ILUMA i in Japan to Accelerate the Achievement of a Smoke-Free Future
- None.
- None.
Insights
The introduction of the IQOS ILUMA i by Philip Morris International represents a significant milestone in the company's strategic shift towards smoke-free products. This move underscores the broader industry trend where traditional tobacco companies are diversifying their portfolios to include reduced-risk products amid increasing regulatory pressures and changing consumer preferences. The claim that IQOS ILUMA i emits 95% lower levels of harmful chemicals compared to cigarettes could strengthen PMI's market position, potentially leading to increased market share in the heat-not-burn (HnB) category.
From a market perspective, PMI's target of having over two-thirds of its total net revenue come from smoke-free products by 2030 is ambitious. Achieving this goal could result in a significant transformation of its revenue streams, reducing dependency on traditional cigarettes. The rapid adoption of IQOS in markets like Japan, where it has reportedly become the number one international nicotine brand, indicates a strong consumer shift towards HnB products. This shift could have a ripple effect on competitors, possibly sparking further innovation and investment in the smoke-free sector.
Financially, the milestone of IQOS net revenues surpassing those of Marlboro is a testament to the product's commercial success and indicates a substantial change in consumer behavior. For investors, the performance of IQOS will be a critical factor to watch, as it could serve as a leading indicator of PMI's future financial health. The company's investment in research and development, as highlighted by the CEO, suggests a commitment to maintaining a competitive edge, which could be favorable for long-term growth.
It is also noteworthy that PMI has achieved a situation where smoke-free product revenues exceed 50% of total net revenue in 25 markets. This diversification could potentially mitigate business risks associated with traditional tobacco sales and align PMI with evolving regulatory landscapes. However, investors should consider the substantial capital required for such R&D and market expansion, which may affect short-term profitability but could be justified if the long-term shift towards smoke-free products continues.
The health implications of the shift towards smoke-free alternatives like the IQOS ILUMA i are significant. The claim of a 95% reduction in harmful chemical emissions, if substantiated, could suggest a reduced health risk for users compared to traditional smoking. This could potentially influence public health policies and regulatory frameworks globally. The role of government and regulatory bodies, as mentioned by the CEO, is indeed crucial in determining the success of such products. Regulatory endorsements or restrictions can have a profound impact on the adoption rates and market penetration of HnB products.
For the medical community, the long-term health effects of these products remain a subject of ongoing research. While the immediate reduction in harmful emissions is a positive step, comprehensive studies are needed to understand the full spectrum of health outcomes associated with prolonged use of HnB products. Such data will be vital for stakeholders, including healthcare providers, regulators and consumers, to make informed decisions.
Celebrates the 10-Year Anniversary of IQOS & Looks Forward to the Next Ten
LAUSANNE,
“We leverage science, world leading brands and commercial capabilities to provide better alternatives to our consumers. This anniversary provides an opportunity to renew our smoke-free vision and our ambition for over two-thirds of our total net revenue to come from smoke-free products by 2030,” said PMI CEO Jacek Olczak. “IQOS ILUMA disrupted the category by introducing induction-heating technology that heats tobacco from within, to provide a consistent taste experience, no tobacco residue, and no need to clean the device. Today, we take IQOS to new heights, with the launch of IQOS ILUMA i—the latest innovation in our smoke-free portfolio, offering a range of advanced features for a clean, seamless, and more flexible experience.”
Over the past 10 years, PMI’s portfolio of scientifically backed smoke-free alternatives, led by IQOS, has created a positive impact on millions of adult smokers and those around them by accelerating an end to cigarettes. Within 10 years, IQOS net revenues have surpassed those for Marlboro, making it the number one international nicotine brand and accelerated the decline of cigarettes in many countries. In
“IQOS ILUMA i is our most innovative offering to date and the new flagship in our portfolio of scientifically substantiated, heat-not-burn smoke-free systems,” said Bertrand Bonvin, President Heat-Not-Burn Platforms at PMI. “Like previous IQOS devices, it emits, on average,
Olczak added: “We have been investing heavily in research and development to provide adults who smoke with better alternatives to cigarettes based on cutting-edge science. But for change to be effectively enacted, government and society at large must play their part. It is important that others—like government authorities and regulators—embrace the opportunity offered by innovation and science to benefit the world.”
IQOS ILUMA i features
The IQOS ILUMA i series offers three devices in
The new touch screen on the device’s holder allows users to see experience-relevant information quickly and easily. To personalize the experience, IQOS ILUMA i introduces a new Pause Mode. By swiping up or down on the touch screen, users can pause and resume their smoke-free moment where they left off5, without worrying about wasting a stick. Additionally, FlexPuff allows users to enjoy the experience at their pace6.
The new IQOS ILUMA i additionally includes smart features like FlexBattery that help prolong the lifespan of the holder’s battery7, contributing to electronic waste reduction, as part of our efforts to reduce the environmental impact of our products. Furthermore, the door for IQOS ILUMA i is made from aluminum produced with renewable energy and the inner textile layer of IQOS ILUMA i’s PRIME leather-like wrap is made of
Further information on IQOS ILUMA i, its features, and additional important information can be found on https://www.IQOS.com.
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is a leading international tobacco company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smoke-free products. Since 2008, PMI has invested
1 Source: PMI global estimate of total In-Market Sales of Heated Tobacco Units as of June 2023.
2 HTU city offtake share [Q3, 2023] of total cigarettes and HTUs. Source: PMI Financials or estimates.
3 Important information: It does not necessarily equal a
4 ”
5 Only available in Performance Mode, during the first 3 minutes or 8 puffs of the experience. When pause is activated, Performance Mode gives you up to two consecutive experiences and pause is available only for one of them.
6 FlexPuff activation and number of puffs depend on individual usage patterns, thus extra puffs might not apply to all adult consumers and/or experiences. FlexPuff does not activate when pause is used.
7 Only when fully used on Eco Mode throughout the lifespan of the holder and may vary depending on personal consumption.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240313137812/en/
Philip Morris International
For media enquiries and visual selects, please contact:
Bryson W. Thornton
+41 (0) 58 242 4500
Bryson.Thornton@pmi.com
Blaine Dodds
+41 (0) 58 242 4500
Blaine.Dodds@pmi.com
Source: Philip Morris International
FAQ
What is the latest addition to Philip Morris International Inc.'s smoke-free products portfolio?
When was IQOS originally launched?
What is the company's revenue goal for smoke-free products by 2030?
How has IQOS impacted cigarette sales in Japan?